Securities code: Betta Pharmaceuticals Co.Ltd(300558) securities abbreviation: Betta Pharmaceuticals Co.Ltd(300558) Announcement No.: 2022036 Betta Pharmaceuticals Co.Ltd(300558)
Notice on convening the 2021 annual general meeting of shareholders
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Betta Pharmaceuticals Co.Ltd(300558) (hereinafter referred to as “the company”) decided at the 30th meeting of the third board of directors to convene the 2021 annual general meeting of shareholders (hereinafter referred to as “the general meeting of shareholders”) at 14:30 on Thursday, April 28, 2022. The relevant matters of the general meeting of shareholders are hereby notified as follows:
1、 Convening and attendance of the meeting
1. Session of the general meeting of shareholders: 2021 annual general meeting of shareholders
2. Convener of the general meeting of shareholders: the general meeting of shareholders was convened by the board of directors of the company upon the resolution of the 30th meeting of the third board of directors of the company.
3. Legality and compliance of the meeting: the proposal on convening the 2021 annual general meeting of shareholders was deliberated and adopted at the 30th meeting of the third board of directors of the company. The convening of the general meeting of shareholders complies with relevant laws and regulations, business rules of Shenzhen Stock Exchange and Betta Pharmaceuticals Co.Ltd(300558) articles of Association.
4. Date and time of the meeting
On site meeting time: 14:30, Thursday, April 28, 2022
Online voting time: April 28, 2022
Among them, the time for online voting through the trading system of Shenzhen stock exchange is 9:15-9:25, 9:30-11:30 and 13:00-15:00 on April 28, 2022; The specific time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 to 15:00 on April 28, 2022.
5. Meeting mode
The shareholders’ meeting adopts the combination of on-site voting and online voting. The shareholders of the company registered on the equity registration date can only choose one of on-site voting and online voting to exercise their voting rights. If there is repeated voting on the same voting right, the first voting result shall prevail.
(1) On site voting: shareholders attend the meeting in person or entrust others to attend the meeting through a power of attorney;
(2) Online voting: the general meeting of shareholders provides all shareholders with an online voting platform through the trading system and Internet voting system of Shenzhen Stock Exchange. Shareholders of the company registered on the equity registration date can exercise their voting rights through the above system during online voting time.
6. Equity registration date: Monday, April 25, 2022
7. Meeting attendees
(1) At the closing of the afternoon of the equity registration day, all the shareholders of the company registered in CSDCC Shenzhen branch who have issued voting shares have the right to attend the shareholders’ meeting, and can entrust an agent to attend and vote in writing. The shareholder agent does not have to be the shareholder of the company. (see Annex 1 for the format of power of attorney)
(2) Directors, supervisors and senior managers of the company;
(3) Lawyers employed by the company;
(4) Other persons who should attend the general meeting of shareholders in accordance with relevant laws and regulations.
8. Venue of the on-site meeting: conference room on the first floor of Betta Pharmaceuticals Co.Ltd(300558) administration building, No. 355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Hangzhou.
2、 Matters considered at the meeting
1. Proposal code table of this shareholders’ meeting
Proposal code proposal name remarks
The column checked in this column can vote
100 total proposals: all the following proposals √
Non cumulative voting proposal
1.00 work report of the board of directors in 2021 √
2.00 work report of the board of supervisors in 2021 √
3.00 financial final accounts report of 2021 √
4.00 full text and summary of 2021 annual report √
5.00 profit distribution plan for 2021 √
6.00 proposal on the remuneration of directors and supervisors of the company in 2021 √
7.00 proposal on reappointment of accounting firm in 2022 √
8.00 proposal on using idle self owned funds for cash management √
9.00 proposal on using idle raised funds for cash management √
10.00 application for comprehensive financing limit and financing amount of the company and its subsidiaries √
Proposal on providing guarantee for internal financing
2. Proposal review and disclosure
The above proposal has been deliberated and adopted at the 30th meeting of the third board of directors and the 24th Meeting of the third board of supervisors. For details, please refer to the announcement on the resolution of the 30th meeting of the third board of directors (Announcement No.: 2022029) and the announcement on the resolution of the 24th Meeting of the third board of supervisors (Announcement No.: 2022030) disclosed by the company on April 7, 2022. The independent directors of the company will report on their work at the annual general meeting of shareholders. For the report of independent directors, please refer to cninfo.com on April 7, 2022.
3. Special tips and instructions
Proposal 10 is a special resolution, which shall be adopted by more than two-thirds of the voting rights held by the shareholders (including shareholders’ agents) attending the general meeting of shareholders.
Proposals 5, 6, 7, 8, 9 and 10 are major issues affecting the interests of small and medium-sized investors. In order to safeguard the interests of all shareholders, especially small and medium-sized shareholders, the company will separately count and disclose the voting results of small and medium-sized investors on all proposals of the general meeting of shareholders (small and medium-sized investors refer to other shareholders except directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the company).
3、 Notes on proposal coding
There are no cumulative voting proposals, mutually exclusive proposals and item by item voting proposals at this shareholders’ meeting. Proposal code 100 is the total proposal. Voting on proposal 100 is deemed to express the same voting opinions on all proposals.
4、 Meeting registration and other matters
1. Registration method
(1) The legal representative or the agent entrusted by the legal representative shall attend the meeting. If the legal representative attends the meeting, he shall go through the registration formalities with the shareholder’s account card, the copy of the business license stamped with the official seal, the certificate of the legal representative and the ID card; If the legal representative entrusts an agent to attend the meeting, the agent shall handle the registration procedures with the agent’s ID card, the copy of the business license stamped with the official seal, the power of attorney issued by the legal representative (see Annex 1 for details), the certificate of the legal representative and the stock account card of the legal person shareholder.
(2) Natural person shareholders shall go through the registration procedures with their own ID card and shareholder account card; If an agent is entrusted to attend the meeting, he must go through the registration formalities with the agent’s ID card, power of attorney (see Annex 1 for details), the principal’s shareholder account card and the principal’s ID card.
(3) Registration of non local shareholders: non local shareholders can register by letter or fax before the registration deadline (they must be delivered or faxed to the company before 17:00 on April 26, 2022, and the letter registration shall be subject to the date of local postmark), and telephone registration is not accepted. Shareholders are requested to carefully fill in the registration form of participating shareholders (see Annex 2 for the format), and attach copies of ID card, unit license and shareholder securities account card for registration confirmation.
2. Registration time: 9:00 a.m. to 17:00 p.m. on Tuesday, April 26, 2022.
3. Place of registration and place of delivery of power of attorney: Securities Department of Beida Pharmaceutical Co., Ltd., No. 355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Hangzhou. Please indicate the words “general meeting of shareholders” in the letter, postcode: 311100.
4. Meeting contact information
Contact: Wu Lingxi, Shen Jianhao
Tel.: 057189265665
Fax: 057189265665
Contact email: [email protected].
5. Precautions
(1) Shareholders and shareholders’ agents attending the on-site meeting shall bring the original of relevant certificates to the venue half an hour before the meeting, so as to sign in and enter the site.
(2) The on-site meeting of the general meeting of shareholders will last for half a day, and the accommodation, transportation and other expenses of the participants shall be borne by themselves. (3) During the epidemic period, the company encouraged and recommended shareholders to give priority to participating in the 2021 annual general meeting of shareholders and exercising their voting rights through online voting.
Shareholders or shareholders’ agents attending the meeting must pay attention to and abide by the epidemic prevention and control policy of Hangzhou in advance, and cooperate with the following work: cooperate with the staff to check the travel card and health code; Carry out temperature measurement and necessary disinfection measures; No symptoms such as fever and cough are confirmed; Confirm that there is no living history in medium and high-risk areas in recent 14 days, and there is no contact with confirmed or suspected cases; When the meeting is held, wear masks and keep the necessary seating distance. Shareholders and their agents who fail to comply with the relevant provisions and requirements of epidemic prevention and control will not be able to enter the meeting site at that time. Please understand.
5、 Specific operation process of participating in online voting
At this shareholders’ meeting, the company will provide shareholders with an online voting platform. Shareholders can vote through the trading system or Internet system of Shenzhen Stock Exchange（ http://wltp.cn.info.com.cn. ）Participate in online voting. See Annex 3 for the specific operation process of online voting.
6、 Documents for future reference
1. Betta Pharmaceuticals Co.Ltd(300558) the resolution of the 30th meeting of the third board of directors.
It is hereby announced.
Betta Pharmaceuticals Co.Ltd(300558) board of directors April 6, 2022 Annex 1: power of attorney
Annex 2: registration form of shareholders attending the meeting
Annex 3: specific operation process of participating in online voting
Power of attorney
I hereby authorize Mr. / Ms. to attend Betta Pharmaceuticals Co.Ltd(300558) 2021 annual general meeting of shareholders on my / our behalf and exercise voting rights on my / our behalf.
Name of client: nature of shares:
Principal’s ID number or business license number:
Principal stock account: number of shares: name of the trustee of the stock (signature): trustee’s ID number:
I / our company voted on the proposal of this shareholders’ meeting as follows:
Remarks: name of the proposal agreeing to oppose the waiver
Code that is checked in this column
Columns can vote
100 total proposals: all the following proposals √
Non cumulative voting proposal
1.00 work report of the board of directors in 2021 √
2.00 work report of the board of supervisors in 2021 √
3.00 financial final accounts report of 2021 √
4.00 full text and summary of 2021 annual report √
5.00 profit distribution plan for 2021 √
On the remuneration of directors and supervisors of the company in 2021
6.00 proposal √
7.00 discussion on renewing the appointment of accounting firm in 2022 √
Case
8.00 √ on cash management with idle self owned funds
